Mutations of the β-catenin gene presumably disrupt these functions, leading to cell proliferation.18–20 In our study, we investigated possible approaches to overcoming MEK inhibitor resistance in colon cancer cells. The gene discussed is MAP2K7; the disease is colonic neoplasm.